cbdMD (YCBD) Operating Expenses (2016 - 2022)
cbdMD (YCBD) reported Operating Expenses of $602092.0 for Q2 2022, down 95.66% on a YoY basis from $13.9 million in Q2 2021, and down 94.74% sequentially from $11.5 million in Q1 2022.
cbdMD (YCBD) Operating Expenses (2016 - 2022) Analysis & Trends
cbdMD (YCBD) has 7 years of Operating Expenses data on file, last reported at $602092.0 in Q2 2022.
- For the quarter ending Q2 2022, Operating Expenses fell 95.66% year-over-year to $602092.0; the trailing twelve-month figure through Mar 2023 stood at $602092.0 (down 98.8% YoY), and the FY2022 full-year result was $602092.0, down 98.79% from the prior year.
- Operating Expenses retreated to $602092.0 in Q2 2022, from $11.5 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $13.9 million in Q2 2021 to a low of -$4.1 million in Q3 2018.
- A 5-year average of $8.1 million and a median of $10.8 million in 2020 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses sank 597.28% in 2018 and jumped 802.44% in 2019, its largest moves.
- Tracing YCBD's Operating Expenses over 5 years: stood at $1.4 million in 2018, then jumped by 802.44% to $12.6 million in 2019, then declined by 15.15% to $10.7 million in 2020, then increased by 12.17% to $12.0 million in 2021, then slumped by 94.96% to $602092.0 in 2022.
- Business Quant data shows YCBD's Operating Expenses at $602092.0 in Q2 2022, $11.5 million in Q1 2022, and $12.0 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 602,092.00 |
| Mar 31, 2022 | 11.45 Mn |
| Dec 31, 2021 | 11.96 Mn |
| Sep 30, 2021 | 12.76 Mn |
| Jun 30, 2021 | 13.87 Mn |
| Mar 31, 2021 | 12.32 Mn |
| Dec 31, 2020 | 10.66 Mn |
| Sep 30, 2020 | 10.90 Mn |
| Jun 30, 2020 | 8.23 Mn |
| Mar 31, 2020 | 12.27 Mn |
| Dec 31, 2019 | 12.56 Mn |
| Sep 30, 2019 | 10.63 Mn |
| Jun 30, 2019 | 11.54 Mn |
| Mar 31, 2019 | 5.75 Mn |
| Dec 31, 2018 | 1.39 Mn |
| Sep 30, 2018 | -4.09 Mn |
| Jun 30, 2018 | 1.46 Mn |
| Mar 31, 2018 | 937,123.00 |
| Dec 31, 2017 | 1.69 Mn |
| Sep 30, 2017 | 822,277.00 |